A new device uses focused sound cues to keep users grounded amid digital distractions, with possible benefits for anxiety and ADHD as well.
The whisper of two palms rubbing together. The squeak of a marker on a whiteboard. The swish of fabric against fabric. The whoosh of a running faucet. These sounds can help center the mind on the present moment.
Such cues were the driving force of new research from Stanford’s SHAPE Lab and the Virtual Human Interaction Lab, which has created a new device they believe can improve mindfulness in an all-too-distracting digital world. The secret is that the keys to mindfulness have been right in front of our ears all along, hidden in the often subtle, overlooked audio cues that help ground us in the beauty and meaning of everyday experiences.
Tumor-treating fields (TTFields) are gaining traction as evidence expands beyond early enthusiasm, Medscape reports. Once considered experimental, TTFields are now supported by multiple randomized trials and are being tested across a growing list of solid tumors, positioning the therapy as a potential addition to standard cancer care in selected patients.
Here’s a look at how it works, the body of evidence, and the limitations.
The electric fields are generated by a wearable device — Optune Gio for glioblastoma and Optune Lua for pleural mesothelioma and NSCLC — developed and marketed by Switzerland-based oncology company Novocure.
Over the past decades, many research teams worldwide have started working on electronic fibers. These are yarn-like components with electronic properties that can be weaved or assembled to create new innovative textile-based electronics, clothes or other wearable systems that can sense their surroundings, monitor specific physiological signals or perform other functions.
Electronic fibers typically contain both regions via which electric current can flow (i.e., conductive domains) and insulating regions that store electric charge (i.e., dielectric domains). Reliably arranging these domains into complex architectures to produce fibers with desired properties can be difficult and most previously introduced methods are difficult to implement on a large scale.
Researchers at École polytechnique fédérale de Lausanne recently demonstrated the potential of a scalable technique known as thermal drawing for creating highly performing, elastomer and liquid metal-based electronic fibers. This approach, outlined in a paper published in Nature Electronics, allowed them to create electronic fibers that were successfully used to fabricate a new textile-based capacitive strain sensor.
Organic light-emitting diodes (OLEDs) power the high-end screens of our digital world, from TVs and phones to laptops and game consoles.
If those displays could stretch to cover any 3D or irregular surfaces, the doors would be open for technologies like wearable electronics, medical implants and humanoid robots that integrate better with or mimic the soft human body.
“Displays are the intuitive application, but a stretchable OLED can also be used as the light source for monitoring, detection and diagnosis devices for diabetes, cancers, heart conditions and other major health problems,” said Wei Liu, a former postdoctoral researcher in the lab of University of Chicago Pritzker School of Molecular Engineering (UChicago PME) Assoc. Prof. Sihong Wang.
A new wearable system uses stretchable electronics and artificial intelligence to interpret human gestures with high accuracy even in chaotic, high-motion environments.
Dr. Cody shows takes a look Graph Theory related to Brain Circuitry and Neurofeedback. ►►►Muse Headband 15% off Discount (applied at checkout): https://choosemuse.com/codyrallmd. ►►►Want to connect with a Myndlift Neurocoach? $60 off with this link: https://signup.myndlift.com/subscription. Enter CODYRALL at checkout.
Cody Rall, M.D., is a United States Navy trained Psychiatrist who specializes in neurotechnology wearables. He is a co-founder of Stanford Brainstorm, the world’s first academic laboratory dedicated to transforming brain health through entrepreneurship.
Dr. Rall also served as a board member of the psychiatry innovation lab, an annual national competition at the American Psychiatric Association that works as an incubator for groups developing technological solutions to problems in mental health care. He is the founder of Techforpsych, a media and relations company that covers advancements in technology related to neuroscience.
In the 1980s when micro-electro-mechanical systems (MEMS) were first created, computer engineers were excited by the idea that these new devices that combine electrical and mechanical components at the microscale could be used to build miniature robots.
The idea of shrinking robotic mechanisms to such tiny sizes was particularly exciting given the potential to achieve exceptional performance in metrics such as speed and precision by leveraging a robot’s smaller size and mass. But making robots at smaller scales is easier said than done due to limitations in microscale 3D manufacturing.
Nearly 50 years later, Ph.D. students Steven Man and Sukjun Kim, working with Mechanical Engineering Professor Sarah Bergbreiter, have developed a 3D printing process to build tiny Delta robots called microDeltas. Delta robots at larger scales (typically two to four feet in height) are used for picking, placing, and sorting tasks in manufacturing, packaging, and electronics assembly. The much smaller microDeltas have the potential for real-world applications in micromanipulation, micro assembly, minimally invasive surgeries, and wearable haptic devices.
Visionary, patient-centric health research for all — dr. julia moore vogel, phd — scripps research / long covid treatment trial.
Dr. Julia Moore Vogel, PhD, MBA is Assistant Professor and Senior Program Director at The Scripps Research Institute (https://www.scripps.edu/science-and-me… where she is responsible for managing a broad portfolio of patient-centric health research studies, including The Long COVID Treatment Trial (https://longcovid.scripps.edu/locitt-t/), a fully remote, randomized, placebo-controlled clinical trial targeting individuals with long COVID, testing whether the drug Tirzepatide can reduce or alleviate symptoms of long COVID.
Prior to this current role, Dr. Vogel managed The Participant Center (TPC) for the NIH All of Us Research Program (https://www.scripps.edu/science-and-me… which was charged with recruiting and retaining 350,000 individuals that represent the diversity of the United States. TPC aims to make it possible for interested individuals anywhere in the US to become active participants, for example by collaborating with numerous outreach partners to raise awareness, collecting biosamples nationwide, returning participants’ results and developing self-guided workflows that enable participants to join whenever is convenient for them.
Prior to joining the Scripps Research Translational Institute, Dr. Vogel created, proposed, fundraised for, and implemented research and clinical genomics initiatives at the New York Genome Center and The Rockefeller University. She oversaw the proposal and execution of grants, including a $44M NIH Center for Common Disease Genomics in collaboration with over 20 scientific contributors across seven institutions. She also managed corporate partnerships, including one with IBM that assessed the relative value of several genomic assays for cancer patients.
Dr. Vogel has a BS in Mathematics from Rensselaer Polytechnic Institute, a PhD in Computational Biology and Medicine from Cornell and an MBA from Cornell.
Conventional wearable ultrasound sensors have been limited by low power output and poor structural stability, making them unsuitable for high-resolution imaging or therapeutic applications.
A KAIST research team has now overcome these challenges by developing a flexible ultrasound sensor with statically adjustable curvature. This breakthrough opens new possibilities for wearable medical devices that can capture precise, body-conforming images and perform noninvasive treatments using ultrasound energy.
